52 Results
Sort By:
Published on September 9, 2024
Researchers in the U.K. have found that the chatbot ChatGPT performed better in assessing complex cases of respiratory illnesses in children than trainee doctors. Analysis of other common chatbots found that Google’s Bard performed better in only some aspects, while Microsoft’s Bing performed as well as trainees. The findings could…
Published on September 11, 2024
A team of scientists supported by the National Institutes of Health (NIH) has developed a promising blood test that could predict the risk of developing severe respiratory diseases, such as chronic obstructive pulmonary disease (COPD). The test analyzes 32 proteins in the blood to determine an individual’s likelihood of needing…
Published on November 17, 2022
Chemicals in the breath of patients admitted to hospital can identify which underlying cardiorespiratory disease they are suffering from, research suggests. Exhaled volatile organic compounds were able to distinguish heart failure, asthma, chronic obstructive pulmonary disease (COPD) and pneumonia, according to the study published in Science Translational Medicine. The “breathomics”…
Published on September 8, 2020
Twist Bioscience has developed the Twist Respiratory Virus Research Panel, a next-generation sequencing (NGS) approach to detecting a wide range of respiratory diseases including SARS-CoV-2, several other coronaviruses, influenzas, rhinoviruses and respiratory syncytial virus. The panel includes both RNA-based and DNA-based viruses in one kit with 41,047 nucleic acid probes.…
Published on March 15, 2024
It is time to stop using terms such as “long COVID” an Australian research team says. Such phrases, they say, imply there is something unique about longer term symptoms associated with COVID. But long COVID, this team maintains, is just a typical post-viral syndrome, indistinguishable from what is seen with…
Published on January 19, 2021
Mammoth Biosciences will apply its DETECTR platform, and IDbyDNA its proprietary pathogen database and algorithms, toward the development of CRISPR-based diagnostics and biosurveillance technologies against varied disease threats for the U.S. Department of Defense (DoD). Mammoth and IDbyDNA are among subcontractors under a four-year, up-to-$36.7 million CRISPR diagnostics contract inked…
Published on April 29, 2020
After preliminary analysis of clinical trial data of the arthritis drug Kevzara showed a benefit only in patients with more advanced “critical” respiratory illness caused by the COVID-19, Sanofi and Regeneron Pharmaceuticals announced they are narrowing the Phase III portion the trial assessing the drug as a treatment for the…
Published on August 5, 2024
By reanalyzing the AncestryDNA COVID-19 study, researchers have found that many genetic risk factors for COVID-19 and influenza do not overlap. The study found that risk factors for each of these respiratory illnesses do share a common feature—they are linked to cell surface proteins that may be required for viral…
Published on April 10, 2024
In a stride towards combating influenza, scientists from the Tufts University School of Medicine, in collaboration with other scientific institutions, have introduced a promising compound, UH15-38, showing the potential to significantly relieve lung damage and inflammation caused by the flu virus. Influenza, a pervasive and often severe respiratory illness, can…
Published on May 23, 2022
Research shows that combining computed tomography (CT) scanning with artificial intelligence (AI) can help to visualize hard to image lung damage caused by respiratory conditions such as COVID-19. The new method, developed by scientists at King Abdullah University of Science and Technology (KAUST) in Saudi Arabia and NorthEast Forestry University,…
Published on January 4, 2021
A small study carried out by NIH researchers suggests that severe COVID-19 can damage the brain via the excessive inflammatory response seen in severe cases of the disease. MRI scans showed damage to small blood vessels in the brain, but no signs of viral RNA were found in tissue samples,…
Published on December 21, 2020
While the most common symptoms of COVID-19 are those of a respiratory illness, there are also a host of other symptoms that relate to the central nervous system. While it remains unclear whether SARS-CoV-2 can enter the brain, new research found that the spike protein can cross the blood-brain-barrier (BBB)…
Published on May 5, 2020
An international team of researchers announced Monday that they have identified a fully human monoclonal antibody that prevents SARS-CoV-2 from infecting cultured cells. Discovery of the antibody, which also neutralizes the related SARS-CoV coronavirus, by scientists from Utrecht University, Erasmus Medical Center, and Harbour BioMed (HBM) represents an initial step…
Published on April 24, 2020
Researchers headed by a team at the University of Illinois, Urbana-Champaign, have developed what they claim is an inexpensive, sensitive smartphone-based device that can detect viral and bacterial pathogens in about 30 minutes, and could be adapted to test for SARS-CoV-2. The platform comprises a cartridge-housed microfluidic chip that carries…
Published on April 9, 2020
Researchers believe a combination of health factors and type II diabetes puts some patients at a higher risk than others for suffering more severe effects of COVID-19. A new study from the National Institute of Health (NIH) may explain why certain populations in the US are more prone to develop…